Bora CDMO

Bora CDMO

X

CAS 161798-01-2 manufacturers and suppliers on PharmaCompass

Product

CAS 161798-01-2

Chemistry, 4 End Use API, 28 Related Intermediates

Manufacturers/Suppliers

4 Suppliers

4 Suppliers

CAS 161798-01-2

Also known as:

Molecular Formula

C₁₄H₁₃NO₄S

Molecular Weight

291.32 g/mol

InChI Key

UIJOKDCOTANGQI-LCYFTJDESA-N

1 2D Structure

CAS 161798-01-2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl (2Z)-2-(3-formyl-4-oxocyclohexa-2,5-dien-1-ylidene)-4-methyl-3H-1,3-thiazole-5-carboxylate

2.1.2 InChI

InChI=1S/C14H13NO4S/c1-3-19-14(18)12-8(2)15-13(20-12)9-4-5-11(17)10(6-9)7-16/h4-7,15H,3H2,1-2H3/b13-9-

2.1.3 InChI Key

UIJOKDCOTANGQI-LCYFTJDESA-N

2.1.4 Canonical SMILES

CCOC(=O)C1=C(NC(=C2C=CC(=O)C(=C2)C=O)S1)C

2.1.5 Isomeric SMILES

CCOC(=O)C1=C(N/C(=C/2\C=CC(=O)C(=C2)C=O)/S1)C

2.2 Create Date

2010-06-17

3 Chemical and Physical Properties

Molecular Formula	C₁₄H₁₃NO₄S
Molecular Weight	291.32 g/mol
XLogP3	1.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	4
Exact Mass	291.05652907 g/mol
Monoisotopic Mass	291.05652907 g/mol
Topological Polar Surface Area	97.8 A^2
Heavy Atom Count	20
Formal Charge	0
Complexity	611
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full View Screen

Full Screen View

price-trend

Waterstone Pharmaceuticals Inc.

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

China

Digital Content

ethyl-2-(3-formyl-4-hydroxy phenyl)-4-methyl thiozole-5...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

161798-01-2

End Use API

Febuxostat

About the Company

Waterstone is an international pharmaceutical company with its main operations in China. The company is ...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

ASK
US

Upload
your Marketing & Sales content

euroapi-m-2024-04-29

Access Virtual Booth

Contact Supplier

Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

Access Virtual Booth

Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search